No abstract available
MeSH terms
-
Aged
-
Coronary Disease / drug therapy*
-
Coronary Disease / mortality
-
Coronary Disease / prevention & control*
-
Female
-
Hormone Replacement Therapy / methods
-
Humans
-
Middle Aged
-
Prognosis
-
Raloxifene Hydrochloride / administration & dosage
-
Risk Assessment
-
Selective Estrogen Receptor Modulators / administration & dosage*
-
Survival Rate
-
Tamoxifen / administration & dosage
-
Treatment Outcome
Substances
-
Selective Estrogen Receptor Modulators
-
Tamoxifen
-
Raloxifene Hydrochloride